{"id":146522,"date":"2023-05-17T08:57:12","date_gmt":"2023-05-17T12:57:12","guid":{"rendered":"https:\/\/44.250.171.167\/?p=146522"},"modified":"2023-05-17T08:57:13","modified_gmt":"2023-05-17T12:57:13","slug":"earnings-summary-of-glaxosmithkline-pharmaceuticals-limited-for-q4-fy23","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earnings-summary-of-glaxosmithkline-pharmaceuticals-limited-for-q4-fy23\/","title":{"rendered":"Earnings Summary Of Glaxosmithkline Pharmaceuticals Limited For Q4 FY23"},"content":{"rendered":"<p>GlaxoSmithKline Pharmaceuticals Limited is a renowned Indian pharmaceutical company that operates in the research, development, manufacturing, and marketing of a wide range of prescription medicines, vaccines, and consumer healthcare products. As a subsidiary of the global healthcare giant Glaxosmithkline, the company carries forward its legacy of innovation, quality, and commitment to improving global health. The company operates through various business segments, including Pharmaceuticals and Consumer Healthcare. The Pharmaceuticals segment focuses on the development, manufacture, and marketing of prescription drugs across multiple therapeutic areas such as respiratory, dermatology, oncology, cardiovascular, and infectious diseases.<\/p>\n<ul>\n<li>GlaxoSmithKline Pharmaceuticals Limited reported Total Income for Q4 FY23 of \u20b9815.11 Crore down from \u20b9828.39 Crore year on year, a decline of 1.6%.<\/li>\n<li>Total Expenses for Q4 FY23 of \u20b9635.54 Crore down from \u20b9650.04 Crore year on year, a decline of 2.2%.<\/li>\n<li>Consolidated Net Profit of \u20b9133.43 Crore, down 89% from \u20b91219.05 Crore in the same quarter of the previous year.<\/li>\n<li>The Earnings per Share is \u20b97.88, from \u20b971.96 in the same quarter of the previous year.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>GlaxoSmithKline Pharmaceuticals Limited is a renowned Indian pharmaceutical company that operates in the research, development, manufacturing, and marketing of a wide range of prescription medicines, vaccines, and consumer healthcare products. As a subsidiary of the global healthcare giant Glaxosmithkline, the company carries forward its legacy of innovation, quality, and commitment to improving global health. The [&hellip;]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392],"tags":[1115],"class_list":["post-146522","post","type-post","status-publish","format-standard","hentry","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":169742,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q1-fy26-earnings-results-revenue-down-1-net-profit-rises-13-yoy\/","url_meta":{"origin":146522,"position":0},"title":"GlaxoSmithKline Pharmaceuticals Ltd Q1 FY26 Earnings Results \u2013 Revenue Down 1%, Net Profit Rises 13% YoY","author":"Divyansh_Kasana","date":"August 4, 2025","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals Limited (GSK Pharma) is a leading pharmaceutical company focused on researching, manufacturing, and making available a broad range of medicines and vaccines that benefit people in India and globally. The company consistently delivers innovation and quality across its therapeutic portfolio. (Source: Company Website) Q1 FY26 Earnings Summary (Apr\u2013Jun\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/GLA.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/GLA.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/GLA.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/GLA.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/GLA.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/GLA.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142467,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-glaxosmithkline-pharmaceuticals-limited-for-q3-fy23\/","url_meta":{"origin":146522,"position":1},"title":"Earnings Summary Of GlaxoSmithKline Pharmaceuticals Limited For Q3 FY23","author":"Hardik Bhandare","date":"February 22, 2023","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO) is a leading pharmaceutical company in India that develops, manufactures, and markets a range of pharmaceutical products for various therapeutic areas. The company has a strong presence in India and a significant global footprint, with operations in more than 150 countries. In terms of earnings,\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-2.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-2.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-2.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-2.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-2.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-2.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165642,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q2fy25-16-rise-in-profits\/","url_meta":{"origin":146522,"position":2},"title":"Glaxosmithkline Pharmaceuticals Ltd Q2FY25; 16% rise in Profits","author":"Divyansh_Kasana","date":"November 14, 2024","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people. Financial Results: Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q2FY25 of \u20b91,011.00 Crores up from \u20b9957.00 Crore year on year, a rise of 5.64%. Total Expenses for Q2FY25 of \u20b9706.00 Crores up from \u20b9686.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/GLAXO.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/GLAXO.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/GLAXO.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/GLAXO.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/GLAXO.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/GLAXO.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169153,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q4fy25-36-rise-in-profits\/","url_meta":{"origin":146522,"position":3},"title":"Glaxosmithkline Pharmaceuticals Ltd Q4FY25; 36% rise in Profits","author":"Divyansh_Kasana","date":"July 16, 2025","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results: Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b9974.00 Crores up from \u20b9930.00 Crore year on year, a rise of 4.73%. Total Expenses for Q4FY25 of \u20b9657.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-10.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-10.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-10.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-10.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-10.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-10.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169166,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q4fy25-36-rise-in-profits-2\/","url_meta":{"origin":146522,"position":4},"title":"Glaxosmithkline Pharmaceuticals Ltd Q4FY25; 36% rise in Profits","author":"Divyansh_Kasana","date":"July 17, 2025","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results: Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b9974.00 Crores up from \u20b9930.00 Crore year on year, a rise of 4.73%. Total Expenses for Q4FY25 of \u20b9657.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167751,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q3fy25-400-rise-in-profits\/","url_meta":{"origin":146522,"position":5},"title":"Glaxosmithkline Pharmaceuticals Ltd Q3FY25; 400% rise in Profits","author":"Divyansh_Kasana","date":"April 4, 2025","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results: Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b9949.00 Crores up from \u20b9805.00 Crore year on year, a rise of 17.89%. Total Expenses for Q3FY25 of \u20b9677.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/146522","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=146522"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/146522\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=146522"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=146522"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=146522"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}